Head & Neck A-2 Protocol A Phase I/II Study of Tolerance and Efficacy of Hyperfractionated Radiation Therapy and 5-Fluorouracil, Cisplatin and Paclitaxel (Taxol) in Stage III and IV Inoperable Head and Neck Squamous Cell Carcinomas

Alan Lewin

Head & Neck A-2 Protocol A Phase I/II Study of Tolerance and Efficacy of Hyperfractionated Radiation Therapy and 5-Fluorouracil, Cisplatin and Paclitaxel (Taxol) in Stage III and IV Inoperable Head and Neck Squamous Cell Carcinomas

Research output: Contribution to conference › Presentation

Original language	American English
State	Published - May 1999
Event	35th Annual Meeting of the American Society of Clinical Oncology (ASCO) - Atlanta, GA Duration: May 1 1999 → …

Conference

Conference	35th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Period	5/1/99 → …

Disciplines

Medicine and Health Sciences

Cite this

Head & Neck A-2 Protocol A Phase I/II Study of Tolerance and Efficacy of Hyperfractionated Radiation Therapy and 5-Fluorouracil, Cisplatin and Paclitaxel (Taxol) in Stage III and IV Inoperable Head and Neck Squamous Cell Carcinomas. / Lewin, Alan.
1999. 35th Annual Meeting of the American Society of Clinical Oncology (ASCO).

Research output: Contribution to conference › Presentation

@conference{f9b8b2bd52264378bd1b211fc1f51e26,

title = "Head \& Neck A-2 Protocol A Phase I/II Study of Tolerance and Efficacy of Hyperfractionated Radiation Therapy and 5-Fluorouracil, Cisplatin and Paclitaxel (Taxol) in Stage III and IV Inoperable Head and Neck Squamous Cell Carcinomas",

author = "Alan Lewin",

year = "1999",

month = may,

language = "American English",

note = "35th Annual Meeting of the American Society of Clinical Oncology (ASCO) ; Conference date: 01-05-1999",

}

TY - CONF

T1 - Head & Neck A-2 Protocol A Phase I/II Study of Tolerance and Efficacy of Hyperfractionated Radiation Therapy and 5-Fluorouracil, Cisplatin and Paclitaxel (Taxol) in Stage III and IV Inoperable Head and Neck Squamous Cell Carcinomas

AU - Lewin, Alan

PY - 1999/5

Y1 - 1999/5

M3 - Presentation

T2 - 35th Annual Meeting of the American Society of Clinical Oncology (ASCO)

Y2 - 1 May 1999

ER -